Trial intelligence / Profile preview

The Effects of Gender-Affirming Hormone Therapy on Biochemical and Body Composition in Trans Men

TCTR20260621005Phase 2Not yet recruiting

Sponsor
Thammasat University
Start
Jun 2026
Countries
1
01

Overview

Phase 2 trial in gender dysphoria (GD), sponsored by Thammasat University. Planned start Jun 2026; status: not yet recruiting.

02

Conditions

gender dysphoria (GD)

Beyond the preview

Go deeper on TCTR20260621005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260621005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call